EGFR and glioblastoma: Finally, the TCGA dataset (The Cancer Genome Atlas Research Network, 2008) supports the prognostic value of the ZEB1/miR-200/c-MYB pathway for glioblastoma, as well as significant co-occurrence of ZEB1, MGMT and ROBO1 in these tumours, and decreased levels of EGFR phosphorylation with reduced ZEB1 expression (Supporting Information Fig S6G and H).